VHCP Management III’s Prevail Therapeutics PRVL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
– Sell
-4,408
Closed -$54K – 24
2019
Q3
$54K Buy
+4,408
New +$50K 0.03% 17

Other funds holding PRVL

VHCP Management III's PRVL Position: Q4 2019 in Review

VHCP Management III sold out of Prevail Therapeutics (PRVL) in Q4 2019, closing a stake of 4,408 shares — an estimated $54K sold.

VHCP Management III first reported a position in PRVL in Q3 2019 and held it in 1 quarter. The position peaked at $54K in Q3 2019. 46 funds tracked by Wall St. Rank hold PRVL as of Q4 2019.

  • VHCP Management III reported no remaining Prevail Therapeutics position as of Q4 2019 after selling out during the quarter.
  • VHCP Management III sold 4,408 Prevail Therapeutics shares in Q4 2019, an estimated $54K.
  • VHCP Management III first reported a position in Prevail Therapeutics in Q3 2019 and held it in 1 quarter.
  • VHCP Management III's Prevail Therapeutics position peaked at $54K in Q3 2019.
  • 46 funds tracked by Wall St. Rank held Prevail Therapeutics as of Q4 2019.

Based on VHCP Management III's 13F filing for Q4 2019, filed 13 Feb 2020.